Veklury (REMDESIVIR) 100MG lyph PWD 20ML SDV

Ended Awarded

Contract number
36C25621F0091
Awardee
Awarding agency
Obligated
$77,850

Award facts

Contract value 100% obligated
$77,850.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Foster City, CA 94404, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

About this award

This is a federal delivery order contract awarded by the Veterans Integrated Service Network (VISN) 16 of the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc., a large biopharmaceutical company. The contract is for the supply of Veklury (remdesivir), a COVID-19 treatment medication. The contract has a ceiling value of $77,850.00 and was awarded on December 23, 2020, with a completion date of January 22, 2021. The contract was awarded under GSA Schedule 61-IB for Pharmaceuticals and Drugs and is a firm fixed-price delivery order. This contract does not utilize any small business set-aside designations, indicating Gilead Sciences Inc. is the prime contractor supplying the medication directly to the VA. Gilead Sciences Inc. is a critical supplier of advanced pharmaceutical products, including cancer immunotherapies and treatments for pulmonary conditions, to various federal healthcare programs, particularly the VA.

Quick answers

Who was awarded contract 36C25621F0091?

36C25621F0091 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on December 23, 2020.

How much is contract 36C25621F0091 worth?

The government has obligated $77,850 on 36C25621F0091.

Is contract 36C25621F0091 an order under another contract?

Yes. 36C25621F0091 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25621F0091 competed?

The extent of competition for 36C25621F0091 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award